Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
IP Group posts narrower first-half loss
(Sharecast News) - IP Group reported a narrower first-half loss on Tuesday as it hailed progress across its portfolio, including a landmark US flotation, while reiterating its confidence in delivering over £250m of exits by 2027. The FTSE 250 deeptech investor posted a net loss of £43m for the six months ended 30 June, down from £109.9m a year earlier, as net asset value per share edged 1.5% lower to 96.2p.
NAV stood at £883.1m, down from £1.07bn at the same point in 2024, though the group said that had since recovered to around 100p per share as of 12 September on the back of gains in its listed holdings.
Portfolio company Hinge Health floated on the New York Stock Exchange at $32 a share and ended the period at $52, valuing IP Group's remaining stake at £39.1m, while Oxford Nanopore beat guidance with £105.6m of first-half revenue and lower losses.
The group also highlighted a series of funding rounds across its holdings, including $15m at Accelercomm, $10m at Lumai, €30m at Tado, €14.2m at Vytal and £12m at Mixergy, with total portfolio fundraising reaching £372m in the half.
Cash proceeds from exits rose ninefold year-on-year to £30.3m, supported by a £25m share buyback completed during the period, with a further £20m extension launched.
IP Group invested £36m across 21 companies and ended the half with gross cash of £237.3m, up from £161.3m a year earlier.
It said fair value gains in its quoted holdings had added £32m since 30 June, including a £23m increase in Oxford Nanopore.
"The group made strong progress in the first half of the year, delivering over £30m in cash proceeds, a near ninefold increase year-on-year," said chief executive Greg Smith.
"The successful IPO of Hinge Health on the NYSE was a standout milestone, and together with gains in Oxford Nanopore, underscores the resilience and quality of our portfolio.
"With NAV per share now at 100p as of 12 September, a strong pipeline of new and maturing companies and improving market sentiment, the group remains confident of delivering more than £250m of exits from private company holdings by the end of 2027.
"As one of the world's most experienced university IP investors, IP Group is uniquely positioned to capitalise on fiscal reform and rising demand for high-growth innovation while remaining firmly focused on delivering long-term value for our shareholders."
At 0824 BST, shares in IP Group were up 0.54% at 55.8p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.